Buch, Englisch, 936 Seiten, Format (B × H): 216 mm x 276 mm, Gewicht: 450 g
Buch, Englisch, 936 Seiten, Format (B × H): 216 mm x 276 mm, Gewicht: 450 g
ISBN: 978-0-323-93606-4
Verlag: Elsevier - Health Sciences Division
- NEW! Drugs for Sexual Dysfunction and Drugs for Transgender Health chapters in a newly combined Reproductive Health unit promote health equity.
- NEW! Drug Decision Guide boxes for selected drugs emphasize a rational process for drug selection.
- NEW! Clinical Pearls boxes highlight expert tips for rational drug prescription.
- NEW! Chapter-opening Evolve links and “Top 300” drug icons throughout identify drugs that appear on the Top 300 prescribed drug list to help you focus your study time.
- ENHANCED! Introductory chapters emphasize prescriber-level pharmacokinetics and pharmacodynamics content.
- NEW! Coverage addresses immunizations and therapeutics (e.g., Regeneron, Resdemivir, dexamethasone) for SARS-CoV-2 infection (COVID-19).
- UPDATED! Enhanced coverage of sexually transmitted infections reflects the latest evidence-based guidelines.
- NEW! Drug content addresses medications for ectoparasite infestations.
- Introductory chapters tailored to the specific needs of beginning prescribers cover topics such as prescriptive authority, rational drug selection and prescription writing, and promoting positive outcomes of drug therapy.
- Carefully focused pharmacotherapeutics content reflects the drugs most commonly seen and used by primary and acute care prescribers, with an emphasis not on the first drug discovered or developed in each drug class, but on the agents most often used today.
- Chapters address primary care drugs first, as appropriate, followed by acute care drugs.
- Prescriber-focused pedagogical aids further reinforce the most important information for prescribers.
- UNIQUE! Summary of Key Prescribing Considerations at the end of each drug chapter provides a concise summary of essential prescriber information.
- Coverage of interprofessional collaboration addresses the growing global emphasis on interprofessional collaboration and incorporates opportunities for interprofessional collaborative practice throughout.
- Integrated coverage of Canadian trade names appears throughout and is highlighted with a familiar maple-leaf icon.
Autoren/Hrsg.
Fachgebiete
Weitere Infos & Material
UNIT I Introduction
UNIT II Basic Principles of Pharmacology
UNIT III Drug Therapy Across the Life Span
UNIT IV Peripheral Nervous System Drugs
UNIT V Central Nervous System Drugs
UNIT VI Drugs for Pain
UNIT VII Psychotherapeutic Drugs
UNIT VIII Substance Use Disorders
UNIT IX Drugs That Affect the Heart, Blood Vessels, Blood, and Blood Volume
UNIT X Drugs for Endocrine Disorders
UNIT XI Reproductive Health
UNIT XII Antiinflammatory, Antiallergic, and Immunologic Drugs
UNIT XIII Drugs for Bone and Joint Disorders
UNIT XIV Respiratory Tract Drugs
UNIT XV Gastrointestinal Drugs
UNIT XVI Nutrition and Complementary Therapies
UNIT XVII Therapy for Infectious and Parasitic Diseases
UNIT XVIII Cancer Therapy
UNIT XIX Drugs for Eyes, Ears, and Skin
UNIT XX Drug Therapy in Acute Care